Authors : Nomula Akhila Reddy; Rubeena Unnisa; Poojitha YB; Shika Samala; Abdul Muqhtadeer; Manas Basak; Suvin N.S

Volume/Issue : Volume 9 - 2024, Issue 4 - April

Google Scholar : https://tinyurl.com/2yuf9fbp

Scribd : https://tinyurl.com/4vdcr9uf

DOI : https://doi.org/10.38124/ijisrt/IJISRT24APR2187

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Lung cancer is characterised by unregulated cell growth. The most prevalent cancer killer worldwide is lung cancer. Lung cancer diagnoses and deaths are rising worldwide. Males and females over 70 have the highest lung cancer risk. Since 50% of lung cancer patients acquire a new cough, smokers or former smokers should be concerned. Lung cancer's complex pathogenesis is yet unknown. Smoking and carcinogen exposure can cause lung epithelial dysplasia. The most prevalent lung cancer diagnosis methods are flexible bronchoscopy and transthoracic sampling. Immunotherapy helps the immune system recognise and fight cancer cells as foreign intruders. Radiation and four to six chemotherapy cycles are usual for mediastinal or hilar lymph node LS-SCLC.

Keywords : Lung Cancer, Small Cell Carcinoma, Large Cell Carcinoma, PET-CT, Bronchoscopy, Programmed Death Receptor.